Vetter Pharma Overview
- Year Founded
-
1950

- Status
-
Private
- Employees
-
7,000

- Latest Deal Type
-
Debt
Vetter Pharma General Information
Description
Manufacturer of clinical products intended to focus on injectable pharmaceutical and biotech compounds. The company provides support for its pharmaceutical and biotech clients in the early stages of development from clinical phases and regulatory approval to worldwide product launch their commercial manufacturing handles the entire production process, enabling clients to avail of the required services.
Contact Information
Website
www.vetter-pharma.comCorporate Office
- Schützenstrasse 87
- 88212 Ravensburg
- Germany
Corporate Office
- Schützenstrasse 87
- 88212 Ravensburg
- Germany
Vetter Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Debt - General | 13-Apr-2023 | Completed | Generating Revenue | |||
2. Debt Refinancing | 19-May-2017 | Completed | Generating Revenue | |||
1. Debt - General | 26-Apr-2012 | Completed | Generating Revenue |
Vetter Pharma Comparisons
Industry
Financing
Details
Vetter Pharma Competitors (57)
One of Vetter Pharma’s 57 competitors is Rottendorf Pharma, a Corporation company based in Ennigerloh, Germany.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Rottendorf Pharma | Corporation | Ennigerloh, Germany | ||||
Ropack Pharma Solutions | Corporation | Montreal, Canada | ||||
CordenPharma | Private Equity-Backed | Plankstadt, Germany | ||||
Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
Lonza Group | Corporation | Basel, Switzerland |
Vetter Pharma Patents
Vetter Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-102023131366-A1 | Closure cap and method for producing a closure cap | Pending | 10-Nov-2023 | ||
CA-220044-S | Syringe cap | Active | 21-Feb-2023 | ||
CA-220045-S | Syringe cap | Active | 21-Feb-2023 | ||
CA-220043-S | Syringe cap | Active | 21-Feb-2023 | ||
US-D1069110-S1 | Syringe cap | Active | 21-Feb-2023 |
Vetter Pharma Signals
Vetter Pharma Investments (2)
Vetter Pharma’s most recent deal was a Corporate Asset Purchase with Vetter Pharma (Clinical Manufacturing Site in Rankweil, Austria). The deal was made on 08-Jul-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Vetter Pharma (Clinical Manufacturing Site in Rankweil, Austria) | 08-Jul-2020 | Corporate Asset Purchase | Buildings and Property | ||
Vetter Pharma (18 Acre Manufacturing Site Based in Illinois, United States) | 12-Jul-2016 | Corporate Asset Purchase | Buildings and Property |
Vetter Pharma Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
RV Invest | Ravensburg, Germany |
Vetter Pharma FAQs
-
When was Vetter Pharma founded?
Vetter Pharma was founded in 1950.
-
Where is Vetter Pharma headquartered?
Vetter Pharma is headquartered in Ravensburg, Germany.
-
What is the size of Vetter Pharma?
Vetter Pharma has 7,000 total employees.
-
What industry is Vetter Pharma in?
Vetter Pharma’s primary industry is Pharmaceuticals.
-
Is Vetter Pharma a private or public company?
Vetter Pharma is a Private company.
-
What is Vetter Pharma’s current revenue?
The current revenue for Vetter Pharma is
. -
Who are Vetter Pharma’s competitors?
Rottendorf Pharma, Ropack Pharma Solutions, CordenPharma, Dalton Pharma Services, and Lonza Group are some of the 57 competitors of Vetter Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »